Dutch validation of the low anterior resection syndrome score

Hupkens, BJP; Breukink, SO; Olde Reuver of Briel, C; Tanis, PJ; de Noo, ME; van Duijvendijk, P; van Westreenen, HL; Dekker, JWT; Chen, TYT; Juul, T

Dutch validation of the low anterior resection syndrome score

Hupkens, BJP Breukink, SO Olde Reuver of Briel, C Tanis, PJ de Noo, ME van Duijvendijk, P van Westreenen, HL Dekker, JWT Chen, TYT

Juul, T

Permalink

Publication Type:: Journal Article
Citation:: Colorectal Disease, 2018, 20 (10), pp. 881 - 887
Issue Date:: 2018-10-01

Closed Access

	Filename	Description	Size
	Hupkens_et_al-2018-Colorectal_Disease.pdf	Published Version	275.25 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Hupkens, BJP	en_US
dc.contributor.author	Breukink, SO	en_US
dc.contributor.author	Olde Reuver of Briel, C	en_US
dc.contributor.author	Tanis, PJ	en_US
dc.contributor.author	de Noo, ME	en_US
dc.contributor.author	van Duijvendijk, P	en_US
dc.contributor.author	van Westreenen, HL	en_US
dc.contributor.author	Dekker, JWT	en_US
dc.contributor.author	Chen, TYT https://orcid.org/0000-0002-1368-8161	en_US
dc.contributor.author	Juul, T	en_US
dc.date.available	2018-03-26	en_US
dc.date.issued	2018-10-01	en_US
dc.identifier.citation	Colorectal Disease, 2018, 20 (10), pp. 881 - 887	en_US
dc.identifier.issn	1462-8910	en_US
dc.identifier.uri	http://hdl.handle.net/10453/129279
dc.description.abstract	Colorectal Disease © 2018 The Association of Coloproctology of Great Britain and Ireland Aim: The aim of this study was to validate the Dutch translation of the low anterior resection syndrome (LARS) score in a population of Dutch rectal cancer patients. Method: Patients who underwent surgery for rectal cancer received the LARS score questionnaire, a single quality of life (QoL) category question and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire. A subgroup of patients received the LARS score twice to assess the test–retest reliability. Results: A total of 165 patients were included in the analysis, identified in six Dutch centres. The response rate was 62.0%. The percentage of patients who reported ‘major LARS’ was 59.4%. There was a high proportion of patients with a perfect or moderate fit between the QoL category question and the LARS score, showing a good convergent validity. The LARS score was able to discriminate between patients with or without neoadjuvant radiotherapy (P = 0.003), between total and partial mesorectal excision (P = 0.008) and between age groups (P = 0.039). There was a statistically significant association between a higher LARS score and an impaired function on the global QoL subscale and the physical, role, emotional and social functioning subscales of the EORTC QLQ-C30 questionnaire. The test–retest reliability of the LARS score was good, with an interclass correlation coefficient of 0.79. Conclusion: The good psychometric properties of the Dutch version of the LARS score are comparable overall to the earlier validations in other countries. Therefore, the Dutch translation can be considered to be a valid tool for assessing LARS in Dutch rectal cancer patients.	en_US
dc.relation.ispartof	Colorectal Disease	en_US
dc.relation.isbasedon	10.1111/codi.14228	en_US
dc.subject.classification	Surgery	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Rectal Neoplasms	en_US
dc.subject.mesh	Rectal Diseases	en_US
dc.subject.mesh	Syndrome	en_US
dc.subject.mesh	Postoperative Complications	en_US
dc.subject.mesh	Reproducibility of Results	en_US
dc.subject.mesh	Psychometrics	en_US
dc.subject.mesh	Quality of Life	en_US
dc.subject.mesh	Translations	en_US
dc.subject.mesh	Adult	en_US
dc.subject.mesh	Aged	en_US
dc.subject.mesh	Middle Aged	en_US
dc.subject.mesh	Netherlands	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.subject.mesh	Surveys and Questionnaires	en_US
dc.subject.mesh	Proctectomy	en_US
dc.title	Dutch validation of the low anterior resection syndrome score	en_US
dc.type	Journal Article
utslib.citation.volume	10	en_US
utslib.citation.volume	20	en_US
utslib.for	1103 Clinical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.issue	10	en_US
pubs.publication-status	Published	en_US
pubs.volume	20	en_US

Abstract:

Colorectal Disease © 2018 The Association of Coloproctology of Great Britain and Ireland Aim: The aim of this study was to validate the Dutch translation of the low anterior resection syndrome (LARS) score in a population of Dutch rectal cancer patients. Method: Patients who underwent surgery for rectal cancer received the LARS score questionnaire, a single quality of life (QoL) category question and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire. A subgroup of patients received the LARS score twice to assess the test–retest reliability. Results: A total of 165 patients were included in the analysis, identified in six Dutch centres. The response rate was 62.0%. The percentage of patients who reported ‘major LARS’ was 59.4%. There was a high proportion of patients with a perfect or moderate fit between the QoL category question and the LARS score, showing a good convergent validity. The LARS score was able to discriminate between patients with or without neoadjuvant radiotherapy (P = 0.003), between total and partial mesorectal excision (P = 0.008) and between age groups (P = 0.039). There was a statistically significant association between a higher LARS score and an impaired function on the global QoL subscale and the physical, role, emotional and social functioning subscales of the EORTC QLQ-C30 questionnaire. The test–retest reliability of the LARS score was good, with an interclass correlation coefficient of 0.79. Conclusion: The good psychometric properties of the Dutch version of the LARS score are comparable overall to the earlier validations in other countries. Therefore, the Dutch translation can be considered to be a valid tool for assessing LARS in Dutch rectal cancer patients.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/129279